IMS Health to Deliver Keynote Address on Orchestrated Customer Engagement at eyeforpharma Barcelona 2016
March 14 2016 - 9:15AM
Business Wire
IMS Health Chief Digital Officer Richie Etwaru will deliver a
keynote address on the opening day of eyeforpharma Barcelona,
underscoring the critical role of end-to-end healthcare stakeholder
engagement in driving better patient outcomes. The 14th annual
eyeforpharma Barcelona conference, to be held March 15-17, is the
world’s leading commercial and patient-centric pharma
event—bringing together industry leaders in commercial
excellence, patient engagement and innovation.
Etwaru’s address, Orchestrated Customer Engagement for Better
Outcomes, will begin at 11:50 a.m. CET on Tuesday, March 15 in the
Main Room of the Centre Convencions Internacional Barcelona. The
presentation will highlight the industry and technology
transformation underway that can lead to greater sales and
marketing precision and place patient outcomes at the core of
commercial operations. An IMS Health white paper on the topic,
Orchestrated Customer Engagement: Orchestrate Every Customer
Experience to Drive Results, also is available.
Additionally, IMS Health will host presentations and workshops
during the eyeforpharma conference on multichannel marketing, sales
excellence, data analytics and patient centricity. Visit the
company’s exhibit area (#41 – 46) for more information.
About IMS Health
IMS Health (NYSE:IMS) is a leading global information and
technology services company providing clients in the healthcare
industry with end-to-end solutions to measure and improve their
performance. Our 7,500 services experts connect configurable SaaS
applications to 10+ petabytes of complex healthcare data in the IMS
One™ cloud platform, delivering unique insights into diseases,
treatments, costs and outcomes. The company’s 15,000 employees
blend global consistency and local market knowledge across 100
countries to help clients run their operations more efficiently.
Customers include pharmaceutical, consumer health and medical
device manufacturers and distributors, providers, payers,
government agencies, policymakers, researchers and the financial
community.
As a global leader in protecting individual patient privacy, IMS
Health uses anonymous healthcare data to deliver critical,
real-world disease and treatment insights. These insights help
biotech and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders to
identify unmet treatment needs and understand the effectiveness and
value of pharmaceutical products in improving overall health
outcomes. Additional information is available at
www.imshealth.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160314005622/en/
IMS HealthTor Constantino, +1
484-567-6732tconstantino@us.imshealth.com
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jul 2023 to Jul 2024